Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review

被引:0
|
作者
Ebrahimi, Niloufar [1 ]
Garimella, Pranav S. [2 ]
Chebib, Fouad T. [3 ]
Sparks, Matthew A. [4 ]
Lerma, Edgar V. [5 ]
Golsorkhi, Mohadese [1 ]
Ghozloujeh, Zohreh Gholizadeh [1 ]
Abdipour, Amir [1 ]
Norouzi, Sayna [1 ]
机构
[1] Loma Linda Univ, Med Ctr, Dept Med, Div Nephrol, Loma Linda, CA 92354 USA
[2] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA USA
[3] Mayo Clin, Div Nephrol & Hypertens, Jacksonville, FL USA
[4] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC USA
[5] Univ Illinois, Dept Med, Sect Nephrol, Chicago, IL USA
来源
KIDNEY360 | 2024年 / 5卷 / 08期
关键词
ADPKD; genetic renal disease; QUALITY-OF-LIFE; IMPACT; MANAGEMENT; PAIN; PERSPECTIVES; OUTCOMES; RISK; CKD;
D O I
10.34067/KID.0000000000000504
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder marked by the development of cysts in the kidneys and other organs, leading to diverse clinical manifestations, including kidney failure. The psychological burden of ADPKD is substantial, with significant contributors including pain, daily life disruptions, depression, anxiety, and the guilt associated with transmitting ADPKD to offspring. This review details the psychological impacts of ADPKD on patients, addressing how they navigate physical and emotional challenges, including pain management, genetic guilt, mood disorders, and disease acceptance. This review also underscores the need for comprehensive research into the psychological aspects of ADPKD, focusing on the prevalence and contributing factors of emotional distress and identifying effective strategies for managing anxiety and depression. Furthermore, it highlights the importance of understanding the diverse factors that influence patients' quality of life and advocates for holistic interventions to address these psychological challenges.
引用
收藏
页码:1200 / 1206
页数:7
相关论文
共 50 条
  • [1] Autosomal Dominant Polycystic Kidney Disease A Review
    Chebib, Fouad T.
    Hanna, Christian
    Harris, Peter C.
    Torres, Vicente E.
    Dahl, Neera K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [2] The Role of Adiposity and Anthropometrics on Disease Progression in Autosomal Dominant Polycystic Kidney Disease: A Narrative Review
    Baris Afsar
    Rengin Elsurer Afsar
    Yasar Caliskan
    Krista L. Lentine
    Current Nutrition Reports, 14 (1)
  • [3] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    DRUGS, 2019, 79 (03) : 303 - 313
  • [4] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2015, 75 (15) : 1797 - 1806
  • [5] Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
    Baur, Brian P.
    Meaney, Calvin J.
    PHARMACOTHERAPY, 2014, 34 (06): : 605 - 616
  • [6] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [7] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Drugs, 2019, 79 : 303 - 313
  • [8] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283
  • [9] Autosomal dominant polycystic kidney disease
    Simms, Roslyn J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [10] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396